Stocks Health care SNDL
NASDAQ · Health careSNDL Inc. (SNDL)
SNDL Inc. reported revenue of CA$1B in fiscal 2025, up 2.8% from a year earlier. It posted a net loss of CA$15.8M. Operating cash flow minus capital spending left CA$58.1M of free cash flow in fiscal 2025. At December 31, 2025 it held CA$252.2M in cash. Its latest periodic report to the SEC is the annual report (Canadian issuer) (40-F) filed on March 12, 2026.
Key facts about SNDL Inc.
- Net worth
- SNDL Inc. has a market value (market cap) of $364.4M at the latest share price, and shareholders' equity of CA$1.1B on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was CA$1B (+2.8% year on year), with a net loss of CA$15.8M.
- Cash flow
- In fiscal 2025 operations brought in CA$70.9M of cash; after CA$12.8M of capital spending, free cash flow was CA$58.1M.
- Latest report
- The latest periodic report (annual report (Canadian issuer), 40-F) was filed with the SEC on March 12, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What SNDL Inc. does
SNDL Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker SNDL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | CA$1B | -CA$15.8M | -CA$0.06 | CA$58.1M |
| 2024 | CA$975.4M | -CA$94.8M | -CA$0.36 | CA$46.3M |
| 2023 | CA$957.7M | -CA$172.7M | -CA$0.67 | -CA$24.5M |
| 2022 | CA$729.7M | -CA$335.1M | -CA$1.46 | -CA$17.4M |
| 2021 | CA$67.3M | -CA$227M | n/a | -CA$159.5M |
| 2020 | CA$73.3M | -CA$233.2M | -CA$1.10 | -CA$60.5M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where SNDL ranks in Health care
Latest SEC filings
What SNDL Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 28, 2026Form SC TO-C filing SC TO-C
- October 27, 2026Form SC TO-C filing SC TO-C
- October 27, 2026
- October 27, 2026
- October 16, 2026Form SC TO-C filing SC TO-C
- October 15, 2026
- October 14, 2026
- October 6, 2026
- September 8, 2026
- August 4, 2026
Insider trades
What the people running SNDL Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Questions about SNDL
What does SNDL Inc. do?
SNDL Inc. is a company in the Health care sector, listed on NASDAQ as SNDL. Its shares trade on NASDAQ under the ticker SNDL.
What is SNDL Inc.'s net worth?
SNDL Inc. has a market value (market cap) of $364.4M at the latest share price, and shareholders' equity of CA$1.1B on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is SNDL Inc. profitable?
No. In fiscal 2025 it reported a net loss of CA$15.8M on revenue of CA$1B.
How much revenue does SNDL Inc. make?
In fiscal 2025 SNDL Inc. reported revenue of CA$1B. That is 2.8% more than a year earlier.
When did SNDL Inc. last report?
Its most recent periodic report is the annual report (Canadian issuer) (40-F) filed on March 12, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the form SC TO-C filing from October 28, 2026.
Similar companies
Compare SNDL with
Follow SNDL
Get an email when SNDL Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values SNDL Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.